期刊文献+

HPV L1壳蛋白联合高危型HPV检测在宫颈病变中的应用价值 被引量:1

The value of diction of HPV L1 capsid protein and human papilloma virus in cervical lesion
原文传递
导出
摘要 目的探讨HPV L1壳蛋白联合高危型人乳头瘤病毒(human papilloma virus,HPV)检测在细胞学异常分流管理及宫颈病变进展评估中的应用价值。方法选择2013年5月—2014年10月收治的液基细胞学(thinprep cytologic test,TCT)结果异常且高危型HPV HC2阳性患者144例作为研究对象,同时行HPV L1壳蛋白检测及宫颈活检,病理检查结果为诊断的金标准。计数资料采用χ2检验,HPV L1壳蛋白阳性率与宫颈病变严重程度的关系采用Spearman相关分析,P<0.05为差异有统计学意义。结果 TCT结果为意义未明的非典型鳞状细胞(atypical squamous cells of undetermined significance,ASCUS)、不能排除高度上皮内瘤变的不典型鳞状细胞(atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion,ASC-H)、轻度鳞状上皮内病变(lower-grade squamous intraepithelial lesions,LSIL)、高度鳞状上皮内病变(high-grade squmous intraepithelial lesions,HSIL)、鳞癌(squamous cell carcinoma,SCC)的HPV阳性率分别为52.78%、57.89%、75.61%、86.67%、100.00%,TCT不同结果患者HPV阳性率比较差异有统计学意义(P<0.05)。HPV L1壳蛋白在宫颈炎、宫颈上皮内瘤变Ⅰ级(cervical intraepithelial neoplasiaⅠ,CINI)、宫颈上皮内瘤变Ⅱ级(cervical intraepithelial neoplasiaⅡ,CINⅡ)、宫颈上皮内瘤变Ⅲ级(cervical intraepithelial neoplasiaⅢ,CINⅢ)、SCC中的表达阳性率分别为52.63%、63.27%、23.08%、9.09%、0,不同病理阶段HPV L1壳蛋白的表达阳性率比较差异有统计学意义(P<0.05)。HPV L1壳蛋白阳性率与宫颈病变严重程度呈负相关(r=-0.912)。结论 HPV L1壳蛋白对宫颈病变风险的评估有重要的指导意义。HPV L1壳蛋白联合高危型HCV检测能对细胞学异常患者进行有效的分流管理与治疗。 Objective To study the clinical value of HPV L1 capsid protein and human papilloma virus(HPV) in clinical triage management and predicting outcome of cervical lesion.Methods 144 patients with HPV DNA detection positive and thinprep cytologic test(TCT) detection abnormal from May 2013 to October 2014 were selected.The HPV L1 caspid protein in cytologic specimens was detected by using immunochemistry and cervical biopsy were performed.All diagnoses were confirmed in histology.Count data was processed by chi square test,the relatiouship between positive rate of HPV L1 capsid protein and severity of cervical cancer were processed by Spearman,P〈0.05 was considered statistically significant.Results The positive rate of HPV in atypical squamous cells of undetermined significance(ASCUS),atypical squamous cells cannot exclude high- grade squamous intraepithelial lesion(ASC- H),lower- grade squamous intraepithelial lesions(LSIL),high- grade squmous intraepithelial lesions(HSIL),squamous cell carcinoma(SCC) were 52.78%,57.89%,75.61%,86.67%,100.00%,the difference was statistically significant(P〈0.05).The positive rate of HPV L1 capsid protein in cervicitis, cervical intraepithelial neoplasia Ⅰ(CINⅠ),cervical intraepithelial neoplasia Ⅱ(CINⅡ),cervical intraepithelial neoplasia Ⅲ(CINⅢ),SCC were 52.63%,63.27%,23.08%,9.09%,0,the difference was statistically significant(P〈0.05).The relationship between positive rate of HPV L1 capsid protein and severity of cervical cancer were negative correlation(r=- 0.912).Conclusion HPV L1 capsid protein detection had important guiding value on risk assessment of cervical lesions.Diction of HPV L1 capsid protein and HPV can accurate diversion and treatment of patients with cervical lesions.
出处 《社区医学杂志》 2015年第17期10-12,共3页 Journal Of Community Medicine
关键词 宫颈病变 人乳头瘤病毒 HPV L1壳蛋白 液基细胞学 Cervical lesion Human papilloma virus HPV L1 capsid protein Thinprep cytology test
  • 相关文献

参考文献12

  • 1Naucler P,Ryd W,Tornberg S,et al.Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical can-cer screening[J].J Natl Cancer Inst,2009,101(2):88-99.
  • 2Soheila S,Izadi-mood N,Pourlashkari M,et aI.HPV L1 capsid protein ex- pression in squamous intraepithelial lesions of cervix uteri and its rele- vance to disease outcome[J].Arch Gynecol Obstet,2012,285(3):779-784.
  • 3盛清,程柯,洪颖,孟凡青.HPV L1壳蛋白在诊断宫颈上皮内瘤变及预测其转归中的临床价值[J].中华临床医师杂志(电子版),2013,7(3):77-80. 被引量:11
  • 4Ranber D,Mehlhorn G,Fasching PA,et al.Prognostic significance of the detection of human papilloma virus LI protein in smears of mild to moderate cervical intraepithelial lesions[J].Eur J Obstet Gynecol Reprod Biol,2008,140(2):258-262.
  • 5Hilfrich R,Hariri J.Prognostic relevance of human papillomavirus LI capsid protein detection within mild and moderate dysplastie lesions of the cervix uteri in combination with pl6 biomarker[J].Anal Quant Cytol Histol,2008,30(2):78-82.
  • 6Griesser H,Sander H,Walczak C,et al.HPV vaccine protein L1 predicts disease outcome of high-risk HPV+ early squamous dysplastic lesions [J].Am J Ciin Pathol,2009,132(6):840-845.
  • 7Negri G,Bellisano G,Zannoni GF,et al.pl6 ink4a and HPV LI im- munohistochemistry is helpful for estimating the behavior of low-grade dysplastie lesions of the cervix uteri [J].Am J Surg Pathol,2008,32(11 ): 1715-1720.
  • 8冷若冰,唐良萏.HPV L1壳蛋白检测联合细胞学在宫颈病变筛查中的临床应用[J].中国现代医学杂志,2011,21(28):3506-3509. 被引量:14
  • 9宋晓霞,刘玉玲,杨晓,王丽丽.HPV L1壳蛋白联合HPV分型、TCT检测技术对子宫颈病变进展风险的评估[J].国际妇产科学杂志,2013,40(2):179-181. 被引量:23
  • 10Galgano MT,Castle PE,Atkins KA,et al.Using biomarkers as objective standards in the diagnosis of cervical biopsies[J].Am J Surg Pathol,2010, 34(8):1077-1087.

二级参考文献65

  • 1Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide:a meta-analysis[ J ]. Br J Cancer,2003,88:63-73.
  • 2Valdespino VM, Valdespino VE. Cervical cancer screening : State of the art [J ]. Curr Opin Obstet Gynecol, 2006, 18:35-40.
  • 3Scheurer ME, Tortdero LG, Adler SK. Human papillomavirus infection : Biology, epidemiology and prevention [ J ]. Int J Gynecol Cancer,2005,15:727-746.
  • 4Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study[ J]. Lancet, 1999,354:20-25.
  • 5Nobbenhuis MA, Hehnerhorst TJ,van den Brule AJ,et al. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear [ J]. Lancet,2001,358 : 1782-1783.
  • 6Nanda K, McCrory DC, Myers ER,et al. Accuracy of the Papanicolaou test in screening for an follow-up of cervical cytologic abnormalities : a systematic review [J ]. Ann Intem Med,2000,132:810-819.
  • 7Stole MH. Human papillomaviruses and cervical neoplasia : A model for carcinogenesis [ J ]. Int J Gyneeol Pathol, 2000,19 : 16-28.
  • 8Pereira R, Hitzeroth Ⅱ , Rybicki EP. Insights into the role and function of L2, the minor capsid protein of papillomaviruses [ J ]. Arch Virol,2009,154 : 187-197.
  • 9McLean CS, Churcher M J, Meinke J, et al. Production and characterisation of a monoclonal antibody to human papil- lomavims type 16 using recombinant vaccinia virus [ J]. J Clin Pathol, 1990,43:488492.
  • 10Melsheimer P, Kaul S, Dobeck S, etal. Immunocytochemical detection of human papillomavirus high risk type LI eapsid proteins in LSIL and HSIL as compared with detection of HPV L1 DNA [ J ]. Acta Cytologica, 2003,47 : 124-128.

共引文献71

同被引文献52

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部